Pramlintide
A synthetic amylin analogue injection that slows gastric emptying and promotes satiety.
Plain English
Patient-Friendly Explanation
Pramlintide is a synthetic version of amylin, a hormone your pancreas releases alongside insulin. It slows digestion and helps you feel full, and it is used mainly in people with diabetes who take insulin. Weight loss is modest, and it is not a first-line weight-loss medicine.
Medical
Clinical Definition
Pramlintide is a synthetic analogue of amylin, a pancreatic beta-cell hormone co-secreted with insulin that acts centrally and peripherally to slow gastric emptying, suppress postprandial glucagon secretion and enhance satiety. It is approved as an adjunct to mealtime insulin in diabetes; trials show modest weight reduction and improved postprandial glucose control. Use is limited by the need for pre-meal injections, nausea, and the risk of severe hypoglycaemia when combined with insulin — insulin doses must be reduced accordingly. It is not a standard choice for obesity pharmacotherapy, though the amylin pathway has informed ongoing development of amylin-based weight-loss agents.
Key Insight
Why It Matters
Pramlintide matters mostly as part of diabetes care — but the amylin pathway it comes from is one of the exciting frontiers in weight-loss research. If you have diabetes and struggle with weight, our doctors can explain how the available options compare.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: August 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.
